Bioassays are used to demonstrate that a biologic product performs per the stated function and potency. Typically, these methods are performed in living systems. Cell-based methods can have inherent variable due to the nature of living systems. Minimizing potential variability can be achieved through careful documentation and analysis of assay performance on control charts. Monitoring numerous parameters may assist laboratory scientists, laboratory managers, QC and QA personnel identify and manage trends that could lead to OOS/OOT results. Since the number of parameters evaluated is dependent on the cell-type, assay-type, and number of critical component or reagents, this webinar will provide a general overview of the topic as well as specific examples of successful monitoring of cell-based methods leading to reduced assay failures.
Course Objective:
• Understanding the variable nature of cell-based methods
• Understanding the critical characteristics of cell-based assays that may affect performance
• Defining critical reagents
• Defining parameters to monitor
• Setting intermediate performance controls
• Details of control charts
• Setting alert and action limits Learn the Four Basic Steps needed for compliance with the FCRA
Course Outline:
Topics covered include:
• Brief introduction to cell-based methods
• Specific areas that may introduce variability in cell-based methods
• Value of control charts
• Risk associated with lack of monitoring of cells and critical reagents
• Best practices for data entry on control charts
• Evaluation of control chart data
• Reporting structures
• Inclusion in written test method
• Training of analysts
What You Get:
• Training Materials
• Live Q&A Session with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points
Who Will Benefit:
This webinar will provide valuable assistance to all personnel in:
• Biopharmaceutical
• Pharmaceutical
• Dietary supplements
FDA Regulatory Control of the Drug Development Process and Investigator Responsibility in the Process
Get Instant Access 90 Minutes View Program |
Biopharmaceutic Considerations in Drug Product Design and In Vitro Drug Product Performance
Get Instant Access 90 Minutes View Program |
Understanding the FDA Compounding Pharmacies Guidance
Get Instant Access 60 Minutes View Program |
Vendor Qualification - Evaluating Vendors & Understanding their Capabilities
Get Instant Access 60 Minutes View Program |
Drug Pharmacy Compounding
Get Instant Access 60 Minutes View Program |
Get Instant Access On-Demand Access
Preparing for the ICE Storm: What to Do During I 9 Audits and ICE Raids
Janette S. Levey
Human Resources
Get Instant Access On-Demand Access
OSHA Inspections and Investigations-How to Manage Them
Irwin Dobrushin
Environment Health and Safety | OSHA
Get Instant Access On-Demand Access
29 CFR 1904: OSHA's New Injury Recordkeeping E-Submission Rule
Occupational Safety and Health Administration
Get Instant Access On-Demand Access
Working with Excel Databases: Sort, Filter, Subtotal and More
Cathy Horwitz
Cross Industry | Skill Enhancement
Get Instant Access On-Demand Access
Writing Audit Reports
Jonnie T. Keith CIA, CFE, CGAP, CICA
Governance, Risk and Compliance
Get Instant Access On-Demand Access
BSA Reporting Requirements
Banking and Financial Services Industry
Get Instant Access On-Demand Access
Human Factors-Usability Based on ISO 62366
Medical Device | Diagnostic | Pharmaceutical | Biologics fields
Get Instant Access On-Demand Access
Chat GPT for Project Managers
Charles H. Paul
All FDA Regulated Industry